Profil
Ashraf Amanullah is currently Chief Technical Operations Officer & Executive VP at Inhibrx Biosciences, Inc. Formerly, Dr. Amanullah was Chief Technical Operations Officer & Executive VP at Sanofi AATD, Inc. from 2018 to 2024, Senior VP-Biologics Development & Manufacturing at aTyr Pharma, Inc. in 2018, Senior Director at Gilead Sciences, Inc. from 2011 to 2015, and Director-Process Development at Genentech, Inc. from 2006 to 2011.
Dr. Amanullah earned a doctorate from the University of Birmingham.
Aktiva positioner av Ashraf Amanullah
| Företag | Position | Start |
|---|
Tidigare kända positioner av Ashraf Amanullah
| Företag | Position | Slut |
|---|---|---|
| INHIBRX, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-05-30 |
| ATYR PHARMA, INC. | Företagsledare/Principal | 2018-07-01 |
| GILEAD SCIENCES, INC. | Direktör/Styrelseledamot | 2015-08-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2011-08-01 |
Ashraf Amanullahs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
















